Drug Trial Radar · NCT06858839
Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
Last checked: Nov 20, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
3,853
Actual
Start
Mar 12, 2025
Primary completion
Jan 21, 2027
Study completion Apr 16, 2027
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Mar 5, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.
Conditions
- Obesity
Interventions
Maridebart CafraglutideDrug
Maridebart cafraglutide will be administered SC.
PlaceboDrug
Placebo will be administered SC.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in Body Weight at Week 72Time frame: Baseline and Week 72
Locations
243 sites in 17 countries. Site status is shown where the registry gives one.
Pinnacle Research Group LLC
Anniston, Alabama
Alliance For Multispecialty Research - Daphne
Daphne, Alabama
Alliance for Multispecialty Research Mobile
Mobile, Alabama
Avacare Foothills Research Center
Phoenix, Arizona
Ark Clinical Research- Tustin
Fountain Valley, California
Long Beach Clinical Trials Services Inc
Long Beach, California
Ark Clinical Research- Long Beach
Long Beach, California
Catalina Research Institute
Montclair, California
Artemis Institute for Clinical Research
Riverside, California
Artemis Institute for Clinical Research
San Diego, California
Apex Clinical Research
San Diego, California
Southern California Clinical Research
Santa Ana, California
Diablo Clinical Research
Walnut Creek, California
Yale School of Medicine
New Haven, Connecticut
Chase Medical Research LLC
Waterbury, Connecticut
Indago Research and Health Center
Hialeah, Florida
Jacksonville Center for Clinical Research
Jacksonville, Florida
Clinical Neuroscience Solutions - Jacksonville
Jacksonville, Florida
South Florida Wellness and Clinical Research Institute
Margate, Florida
Optimus U Corporation
Miami, Florida
Research Institute of South Florida
Miami, Florida
Renstar Medical Research
Ocala, Florida
Clinical Neuroscience Solutions - Orlando
Orlando, Florida
Combined Research Orlando Phase I IV
Orlando, Florida
Florida Institute for Clinical Research
Orlando, Florida
Encore Medical Research of Weston LLC
Weston, Florida
Center for Advanced Research and Education
Gainesville, Georgia
Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group
Union City, Georgia
East-West Medical Research
Honolulu, Hawaii
Solaris Clinical Research
Meridian, Idaho
Flourish Research - Great Lakes Clinical Trials
Chicago, Illinois
Endeavor Health Medical Group - Endocrinology and Diabetes- Skokie
Skokie, Illinois
Evanston Premier Healthcare Research LLC
Skokie, Illinois
Alliance for Multispecialty Research Newton
Newton, Kansas
Louisville Metabolic and Atherosclerosis Research Center
Louisville, Kentucky
Velocity Clinical Research - Baton Rouge
Baton Rouge, Louisiana
Tandem Clinical Research - Marrero
Marrero, Louisiana
Headlands Research - Detroit
Southfield, Michigan
Prime Health and Wellness Sky Clinical Research Network Group
Fayette, Mississippi
Alliance for Multispecialty Research - Kansas City
Kansas City, Missouri
Showing 40 of 243 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.